Journal profile · PHARMACOLOGY & PHARMACY
Recent Patents on Inflammation & Allergy Drug Discovery
ISSN 1872-213X · eISSN 2212-2710 · Bentham
FollowGet an email when its zone, impact factor or warning status changes
Recent Patents on Inflammation & Allergy Drug Discovery: subscription journal; 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Recent Patents on Inflammation & Allergy Drug Discovery is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Inflammatory mediators and NSAID effects, together about 39.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine21.1%
- Allergic Rhinitis and SensitizationMedicine10.4%
- Inflammatory mediators and NSAID effectsMedicine8.3%
- Intellectual Property and PatentsBusiness, Management and Accounting6.2%
- Food Allergy and Anaphylaxis ResearchMedicine5.8%
- Contact Dermatitis and AllergiesMedicine5.3%
- Dermatology and Skin DiseasesMedicine5.1%
- Mast cells and histamineImmunology and Microbiology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Drug Discovery | Q3 | 76/145 | 47th |
| Immunology and Allergy | Q3 | 107/182 | 41st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 3.9LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 1.2LetPub ·
- h-index
- 44OpenAlex ·
- i10-index
- 164OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 385 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 391 |
| 2025 | 0 | 0 | 747 |
| 2024 | 0 | 0 | 904 |
| 2023 | 0 | 0 | 873 |
| 2022 | 0 | 0 | 944 |
| 2021 | 0 | 0 | 757 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Before you submit
Three checks before submitting to Recent Patents on Inflammation & Allergy Drug Discovery
- 1ScopeRecent output centres on Asthma and respiratory diseases, Allergic Rhinitis and Sensitization.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1872-213X
- Electronic ISSN
- 2212-2710
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Recent Patents on Inflammation & Allergy Drug Discovery
Which databases index Recent Patents on Inflammation & Allergy Drug Discovery?
According to LetPub and DOAJ records, Recent Patents on Inflammation & Allergy Drug Discovery is indexed in Scopus.
Is Recent Patents on Inflammation & Allergy Drug Discovery open access, and what is the APC?
Recent Patents on Inflammation & Allergy Drug Discovery is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .